These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

924 related articles for article (PubMed ID: 18361212)

  • 1. [BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].
    Valle R; Aspromonte N; Carbonieri E; De Michele G; Di Tano G; Giovinazzo P; Cioè R; Di Giacomo T; Milani L; Noventa F; Chiatto M
    Monaldi Arch Chest Dis; 2007 Sep; 68(3):154-64. PubMed ID: 18361212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.
    Faggiano P; Valle R; Aspromonte N; D'Aloia A; Di Tano G; Barro S; Giovinazzo P; Milani L; Lorusso R; Dei Cas L
    Int J Cardiol; 2010 Apr; 140(1):88-94. PubMed ID: 19321212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function.
    Valle R; Aspromonte N; Feola M; Milli M; Canali C; Giovinazzo P; Carbonieri E; Ceci V; Cerisano S; Barro S; Milani L
    J Card Fail; 2005 Sep; 11(7):498-503. PubMed ID: 16198244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of plasma brain natriuretic peptide, urea nitrogen, and creatinine in outpatients >70 years of age with heart failure.
    Feola M; Aspromonte N; Canali C; Ceci V; Giovinazzo P; Milani L; Quarta G; Ricci R; Scardovi AB; Uslenghi E; Valle R
    Am J Cardiol; 2005 Sep; 96(5):705-9. PubMed ID: 16125500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of plasma brain natriuretic peptide for cardiac events in elderly patients with congestive heart failure.
    Tamura K; Takahashi N; Nakatani Y; Onishi S; Iwasaka T
    Gerontology; 2001; 47(1):46-51. PubMed ID: 11244291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
    Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
    J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy.
    Dini FL; Conti U; Fontanive P; Andreini D; Panicucci E; De Tommasi SM
    Am J Cardiol; 2008 Aug; 102(4):463-8. PubMed ID: 18678307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction.
    Price JF; Thomas AK; Grenier M; Eidem BW; O'Brian Smith E; Denfield SW; Towbin JA; Dreyer WJ
    Circulation; 2006 Sep; 114(10):1063-9. PubMed ID: 16940194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of galectin-3 and plasma B type-natriuretic peptide in predicting prognosis in discharged chronic heart failure patients.
    Feola M; Testa M; Leto L; Cardone M; Sola M; Rosso GL
    Medicine (Baltimore); 2016 Jun; 95(26):e4014. PubMed ID: 27368017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.
    Logeart D; Thabut G; Jourdain P; Chavelas C; Beyne P; Beauvais F; Bouvier E; Solal AC
    J Am Coll Cardiol; 2004 Feb; 43(4):635-41. PubMed ID: 14975475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of brain natriuretic peptide after acute myocardial infarction.
    Güneş Y; Okçün B; Kavlak E; Erbaş C; Karcier S
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):182-7. PubMed ID: 18524723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence and predictors of left ventricular systolic dysfunction at hospital discharge and in long-term follow-up after acute myocardial infarction treated with primary percutaneous coronary intervention.
    Świątkiewicz I; Magielski P; Woźnicki M; Gierach J; Jabłoński M; Fabiszak T; Koziński M; Sukiennik A; Bronisz A; Kubica J
    Kardiol Pol; 2012; 70(4):329-40. PubMed ID: 22528703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of brain natriuretic peptide in the management of patients receiving cardiac resynchronization therapy.
    Pitzalis MV; Iacoviello M; Di Serio F; Romito R; Guida P; De Tommasi E; Luzzi G; Anaclerio M; Varraso L; Forleo C; Pansini N
    Eur J Heart Fail; 2006 Aug; 8(5):509-14. PubMed ID: 16503416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
    Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
    J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
    Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical status and B-type natriuretic peptide levels in patients with heart failure at hospital discharge.
    Oral I; Mistrík J; Náplava R
    Herz; 2007 Oct; 32(7):583-8. PubMed ID: 17972033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
    Ang DS; Kong CF; Kao MP; Struthers AD
    Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure.
    Goonewardena SN; Gemignani A; Ronan A; Vasaiwala S; Blair J; Brennan JM; Shah DP; Spencer KT
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):595-601. PubMed ID: 19356487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.